2023-24137. National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meeting  

  • Start Preamble

    Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Board of Scientific Counselors, NIDDK.

    The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.

    The meeting will be closed to the public as indicated below in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended for the review, discussion, and evaluation of individual grant applications conducted by the National Institute Of Diabetes And Digestive And Kidney Diseases, including consideration of personnel qualifications and performance, and the competence of individual investigators, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Board of Scientific Counselors, NIDDK.

    Date: September 26–27, 2024.

    Open: September 26, 2024, 10:00 a.m. to 10:20 a.m.

    Agenda: Introductions and Overview.

    Place: National Institutes of Health, Building 10, 10 Center Drive, Bethesda, MD 20892 (Virtual Meeting).

    Closed: September 26, 2024, 10:30 a.m. to 5:00 p.m.

    Agenda: To review and evaluate personal qualifications and performance, and competence of individual investigators.

    Place: National Institutes of Health, Building 10, 10 Center Drive, Bethesda, MD 20892 (Virtual Meeting).

    Contact Person: Michael W. Krause, Ph.D. Scientific Director, NIDDK, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Health, Building 5, Room B104, Bethesda, MD 20892–1818 (301) 402–4633 mwkrause@helix.nih.gov.

    (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS)

    Start Signature

    Dated: October 27, 2023.

    Miguelina Perez,

    Program Analyst, Office of Federal Advisory Committee Policy.

    End Signature End Preamble

    [FR Doc. 2023–24137 Filed 11–1–23; 8:45 am]

    BILLING CODE 4140–01–P

Document Information

Published:
11/02/2023
Department:
National Institutes of Health
Entry Type:
Notice
Document Number:
2023-24137
Dates:
September 26-27, 2024.
Pages:
75300-75300 (1 pages)
PDF File:
2023-24137.pdf